CNBX Pharmaceuticals Inc.
CNBX
$0.00
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -367.60K | -393.30K | -314.00K | -224.50K | -295.40K |
| Total Depreciation and Amortization | -- | -- | -- | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.20K | 83.00K | 39.80K | 56.50K | 42.30K |
| Change in Net Operating Assets | 162.90K | 130.60K | 102.80K | -23.00K | 114.30K |
| Cash from Operations | -158.40K | -179.60K | -171.30K | -191.10K | -138.90K |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 94.70K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 0.00 | 94.70K |
| Total Debt Issued | 125.00K | 170.00K | 160.00K | 131.30K | 112.60K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 125.00K | 170.00K | 160.00K | 131.30K | 112.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -59.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -33.40K | -9.60K | -11.30K | -59.80K | 8.50K |